NO149281C - Analogifremgangsmaate til fremstilling av terapeutisk aktive 7alfa-metoksycephalosporinderivater - Google Patents

Analogifremgangsmaate til fremstilling av terapeutisk aktive 7alfa-metoksycephalosporinderivater

Info

Publication number
NO149281C
NO149281C NO744222A NO744222A NO149281C NO 149281 C NO149281 C NO 149281C NO 744222 A NO744222 A NO 744222A NO 744222 A NO744222 A NO 744222A NO 149281 C NO149281 C NO 149281C
Authority
NO
Norway
Prior art keywords
methoxyphalosporine
7alfa
derivatives
preparation
therapeutically active
Prior art date
Application number
NO744222A
Other languages
English (en)
Norwegian (no)
Other versions
NO744222L (zh
NO149281B (no
Inventor
Hideo Nakao
Hiroaki Yanagisawa
Mitsuo Nagano
Bunji Shimizu
Masakatsu Kanebo
Shinichi Sugawara
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP13244173A external-priority patent/JPS5417755B2/ja
Priority claimed from JP13244273A external-priority patent/JPS5624676B2/ja
Priority claimed from JP14209773A external-priority patent/JPS5442999B2/ja
Priority claimed from JP9212974A external-priority patent/JPS5123285A/ja
Priority claimed from JP9213174A external-priority patent/JPS5123286A/ja
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NO744222L publication Critical patent/NO744222L/no
Publication of NO149281B publication Critical patent/NO149281B/no
Publication of NO149281C publication Critical patent/NO149281C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/12—Oxygen atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO744222A 1973-11-26 1974-11-25 Analogifremgangsmaate til fremstilling av terapeutisk aktive 7alfa-metoksycephalosporinderivater NO149281C (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP13244173A JPS5417755B2 (zh) 1973-11-26 1973-11-26
JP13244273A JPS5624676B2 (zh) 1973-11-26 1973-11-26
JP14209773A JPS5442999B2 (zh) 1973-12-18 1973-12-18
JP9212974A JPS5123285A (en) 1974-08-12 1974-08-12 77 metokishisefuarosuhorinjudotaino seiho
JP9213174A JPS5123286A (ja) 1974-08-12 1974-08-12 Sefuarosuhorinjudotaino seiho

Publications (3)

Publication Number Publication Date
NO744222L NO744222L (zh) 1975-06-23
NO149281B NO149281B (no) 1983-12-12
NO149281C true NO149281C (no) 1984-03-21

Family

ID=27525582

Family Applications (1)

Application Number Title Priority Date Filing Date
NO744222A NO149281C (no) 1973-11-26 1974-11-25 Analogifremgangsmaate til fremstilling av terapeutisk aktive 7alfa-metoksycephalosporinderivater

Country Status (14)

Country Link
US (1) US4007177A (zh)
BE (1) BE822616A (zh)
CA (1) CA1060432A (zh)
CH (1) CH611906A5 (zh)
DE (1) DE2455884C3 (zh)
DK (1) DK146538C (zh)
FR (1) FR2252100B1 (zh)
GB (1) GB1449420A (zh)
HU (1) HU169922B (zh)
IE (1) IE40220B1 (zh)
NL (3) NL172327C (zh)
NO (1) NO149281C (zh)
PH (1) PH14530A (zh)
SE (1) SE420201B (zh)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1348985A (en) * 1970-06-16 1974-03-27 Merck & Co Inc Esters of cephalosporin compounds
JPS5641637B2 (zh) * 1973-11-26 1981-09-29
US4059578A (en) * 1974-09-09 1977-11-22 Smithkline Corporation 7-Substituted mercaptoacetamido cephamycins
US4101657A (en) * 1975-01-13 1978-07-18 Smithkline Corporation Cephamycins as antibacterial agents
US4126745A (en) 1975-04-30 1978-11-21 Sankyo Company Limited 7-Methoxycephalosporin derivatives
DE2539214C2 (de) * 1975-09-03 1984-03-29 E.R. Squibb & Sons, Inc., 08540 Princeton, N.J. 7-Methoxythienyl-ureido-cephalosporin und dieses enthaltendes Arzneimittel
IL50546A (en) * 1975-10-30 1980-07-31 Smithkline Corp 7-acyl-3-(1-(2-sulfaminoethyl)tetrazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid derivatives and pharmaceutical compositions containing them
JPS6026800B2 (ja) * 1976-01-22 1985-06-25 富山化学工業株式会社 新規な７α−メトキシセフアロスポリン類およびその製造法
GR61146B (en) * 1976-03-25 1978-09-27 Shionogi & Co Preparation process of 1-oxadethiacephalosporins analogues
US4053605A (en) * 1976-06-15 1977-10-11 Merck & Co., Inc. Esterified-2(3-lower-alkyl-amino-propoxy)-3-cyano-pyridines and derivatives
US4165429A (en) * 1976-06-28 1979-08-21 Yamanouchi Pharmaceutical Co., Ltd. 7α-METHOXY-CEPHALOSPORANIC ACID DERIVATIVES
JPS5331690A (en) * 1976-09-01 1978-03-25 Shionogi & Co Ltd Oxadithiacephalosporins
GB1579533A (en) * 1977-03-26 1980-11-19 Farmaceutici Italia Cephalosporins and their preparation
US4229573A (en) * 1977-06-21 1980-10-21 Asahi Kasei Kogyo Kabushiki Kaisha 7α-Methoxycephalosporin derivatives
JPS6052713B2 (ja) * 1978-04-11 1985-11-20 三共株式会社 ７−メトキシセフアロスポリン化合物、その製法及びその化合物を主成分とする抗菌剤
JPS5583791A (en) * 1978-12-18 1980-06-24 Meiji Seika Kaisha Ltd 7-methoxycephalosporin derivative and its preparation
JPS59128392A (ja) * 1982-12-29 1984-07-24 Kureha Chem Ind Co Ltd セフアロスポリン誘導体及び該誘導体を含有する薬剤
JP5703009B2 (ja) * 2010-12-16 2015-04-15 住友精化株式会社 スルホン化合物、スルホン化合物の製造方法、および電気化学デバイス用電解液
CN104557978B (zh) * 2014-12-31 2017-07-18 重庆福安药业(集团)股份有限公司 一种头孢美唑钠的制备方法
EP3178643A1 (en) 2015-12-10 2017-06-14 Danmarks Tekniske Universitet Method of manufacturing a composite structure including a textile fabric assembly
KR102188689B1 (ko) 2018-12-04 2020-12-09 (주)유케이케미팜 세프메타졸 소듐의 제조 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3530123A (en) * 1966-11-02 1970-09-22 Fujisawa Pharmaceutical Co 3-thiolated-7-sydnone-acylamino-cephalosporanic acid derivatives
GB1348985A (en) * 1970-06-16 1974-03-27 Merck & Co Inc Esters of cephalosporin compounds
US3887549A (en) * 1971-11-19 1975-06-03 Merck & Co Inc Process for preparing 7-acylamido-7-methoxy-3-cephem-4-carboxylic acid, esters and salts
US3905963A (en) * 1972-01-25 1975-09-16 Lilly Co Eli Process for preparing primary 3-carbamoyloxymethyl cephalosporins
US3840531A (en) * 1972-03-21 1974-10-08 Lilly Co Eli Process for preparing 7-(alpha-hydroxy-alpha-phenyl)acetamido-3-(1-methyl-1h-tetrazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid and derivatives thereof
US3920639A (en) * 1973-04-23 1975-11-18 Squibb & Sons Inc Cyanomethylthioacetyl-7-methoxycephalosporins
US3883520A (en) * 1973-08-17 1975-05-13 Smithkline Corp Substituted mercaptoacetamidocephalosporins

Also Published As

Publication number Publication date
CA1060432A (en) 1979-08-14
DK146538B (da) 1983-10-31
DK611374A (zh) 1975-07-28
DE2455884A1 (de) 1975-05-28
US4007177A (en) 1977-02-08
PH14530A (en) 1981-08-31
NL8205006A (nl) 1983-04-05
IE40220L (en) 1975-05-26
NL172327B (nl) 1983-03-16
DE2455884B2 (de) 1981-01-22
NO744222L (zh) 1975-06-23
NO149281B (no) 1983-12-12
GB1449420A (en) 1976-09-15
AU7573974A (en) 1976-05-27
DE2455884C3 (de) 1981-11-19
HU169922B (zh) 1977-02-28
SE420201B (sv) 1981-09-21
IE40220B1 (en) 1979-04-11
BE822616A (fr) 1975-05-26
DK146538C (da) 1984-04-09
NL7415432A (nl) 1975-05-28
SE7414706L (zh) 1975-05-27
NL8205005A (nl) 1983-04-05
FR2252100A1 (zh) 1975-06-20
NL172327C (nl) 1983-08-16
FR2252100B1 (zh) 1978-07-28
CH611906A5 (zh) 1979-06-29

Similar Documents

Publication Publication Date Title
NO141407C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive etylenderivater
NO146200C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme 16-oksygenerte prostansyrederivater
NO149106C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive benzcykloamider
NO147450C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolonderivater
NO145576C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive penicillinderivater
NO149281C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 7alfa-metoksycephalosporinderivater
NO145056C (no) (s)-1-aryloksy-2-propanolderivater for fremstilling av terapeutisk aktive (s)-1-aryloksy-3-amino-2-propanolderivater
NO141717C (no) Analogifremgangsmaate til fremstilling av farmakologisk aktive triazolopyridaziner
NO142303C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme oksazolderivater
NO142838C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater
NO141850C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive pyrazolderivater.
NO141755C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme dotriacontapeptidamider
NO141649C (no) Analogifremgangsmaate for fremstilling av neuroleptisk aktive 7-fluorsubstituerte fenotiaziner
SE7712151L (sv) Forfarande for framstellning av linkomycinderivat
NO141894C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive pyridobenzodiazepinoner
NO143064C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksyalkylxantiner
NO141262C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme tripeptider
NO142260C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tienotriazolodiazepinderivater
NO140012C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive derivater av naftyridin
SE417319B (sv) Analogiforfarande for framstellning av ergopeptiner
NO143499C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indanderivater
NO145238C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydrokarbostyril-derivater
NO141441C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive derivater av isoindolin-1-on
NO144110C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5:6-benzo-4-pyron-derivater
NO147754C (no) Analogifremgangsmaate ved fremstilling av terapeutisk virksomme cefemderivater.